Page 2 - Pharmacy

India looking at greater market access for pharma products in UK under FTA

India is looking at greater market access for its pharmaceutical products in the UK as part of the proposed free trade agreement with Britain, an official said on Friday. The official also said that a leaked chapter of the agreement, which is floated on some portals, on intellectual property (IP) is edited, distorted, and is a manipulated version of an initial document of the UK. "The best part in the proposed agreement is that both sides have highlighted their red lines and sensitivities. Ever-greening and touching manufacturing of generic medicines is completely non-negotiable," the official added. India has already secured greater market access for the domestic pharma industry in a trade pact with the UAE. Under the pact, Indian pharmaceutical products and medical goods will get regulatory approval within 90 days that have been approved in developed jurisdictions such as the US, the UK, the EU, Canada, and Australia. Similarly, the India-Australia trade deal would provide ...

We won't make an acquisition just because we have to: Piramal Pharma chief

In a Q&A, Nandini Piramal, chairperson of the firm, says the company currently sees great scope in expanding and organically growing the OTC business, and wants to build more consumer focused brands

Maiden Pharma may lose import-export code over cough syrup deaths in Gambia

Pharmexcil suspends membership; may recommend DGFT to withdraw Import-Export Code

CSAB NEUT 2022 registration open till October 12; here's how to apply

Candidates will need their JEE Main roll number and password to log in and fill out the application form

Advisory board urges ban on codeine cough drugs, regulator to take call

Codeine formulations constitute 8% of cough and cold market; pharma industry asks govt not to ban a 'safe' medicine for abuse by some

Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more

From World Bank slashing India's economic growth to Maiden Pharma's cough syrup issue, here are the top headlines on Friday morning

Registration by medical device resellers made a must, may impact mask sales

Apart from masks, even condoms sold at groceries may be brought within the ambit of the rule; industry feels govt may come out with an exemption list for common items

Udaan starts multiple deliveries per day for pharmacies in six cities

Softbank-backed B2B e-commerce firm Udaan has started delivering stocks to pharmacies four times a day across six cities and plans to scale up the service to other places after six to eight months, the company said on Thursday. The 4X4 delivery service' has been rolled out after a pilot programme and receiving extensive feedback from pharmacies in select cities, which required enhanced delivery capabilities. During the pilot phase, the business witnessed a 45 per cent rise in orders in the select cities. "As part of the new service offering, Udaan will provide medicine delivery to pharmacies every 4-hour with 4 delivery slot options in a day to order medicines across six cities - Kolkata, Jaipur, Indore, Ahmedabad, Bengaluru and Pune. Udaan plans to scale the '4X4 delivery service' to more cities and towns in the next 6-8 months," the company said in a statement. Udaan Business head for Pharma Category Sanjay Sharma said the company will leverage for the convenience and faster ...

Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August

Centre looking to phase out codeine-based cough syrups, select FDCs

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants

India sets up export promotion council for medical devices under DoP

India currently exports Rs. 23,766 crore (2021-22) of medical devices up from previous year Rs 19,736 crore

Govt forms 5-member committee to review pharma marketing practices

It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days

Core brands, new launches to help Abbott India stock outperform: Analysts

Analysts expect double-digit growth for pharma major even if Q1 disappointed

Bharat Biotech awaits booster dose nod for intranasal vaccine iNCOVACC

Bharat Biotech did not comment on its plans to make this vaccine available for young children

Online pharmacy platform Tata 1mg turns unicorn after raising $40 mn

Funding round was led by Tata Digital; Tata 1mg has become 105th unicorn in India

Molbio Diagnostics looking to expand test menu on its Truenat platform

The company is also open to raising funds and has been in talks with PE and VC funds for the same

Start-ups collaborate with chemists, shake up offline pharma business

Some are managing supply-chain backend for retail pharmacies, right from stockist to chemist, others are offering telemedicine kiosks at chemist outlets, and digitising pharmacies

Going off-patent, key diabetes drug likely to get 50-70% cheaper

Merck's Sitagliptin set to lose patent this month; around 200 brands from 50 firms may enter the market

Trade gap widens to record $25.6 bn; imports surge to $63.58 bn in June

India's traditional high dependence on crude oil led to its imports soaring 94.2 per cent in June to $20.7 billion

Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum

Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers